Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.50    0.00 (0.00%)
Bid:
302.50
Ask:
303.00
Spread: 0.50 (0.165%)
Market Cap: £178.58m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Form 8 (Opening Position Disclosure)

1 May 2026 15:50

RNS Number : 8720C
Treatt PLC
01 May 2026
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Treatt PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Treatt PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

30 April 2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 2 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Director

Number of ordinary shares in Treatt held

Percentage of total issued share capital (%)

Vijay Thakrar

10,760

0.01%

Sangita Shah

 

11,441

0.01%

Total

22,201

0.02%

 

Options over shares

 

Name

Treatt Share Plan under which award was granted

Number of ordinary shares in Treatt subject to award

Date of grant

Vesting date(s)

 

 

 

 

Expiry date

Exercise price

Manprit Randhawa

LTIP 2024

 

209,215

 

11 February 2026

 

11 February 2029

 

11 February 2036

 

Nil cost option

 

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

1 May 2026

Contact name:

Nick Hartigan

Telephone number:

+44 1284 702 500

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBSGDUISGDGLB
Date   Source Headline
29th Jan 20211:59 pmRNSResult of AGM
22nd Jan 20217:00 amRNSTrading Update
13th Jan 20214:40 pmRNSDirector/PDMR Shareholding
12th Jan 20213:20 pmRNSDirector/PDMR Shareholding
11th Jan 20219:27 amRNSDirector Declaration
21st Dec 20203:23 pmRNSTotal Voting Rights
21st Dec 202010:28 amRNSChanges to 2021 AGM Arrangements
16th Dec 20205:16 pmRNSDirector/PDMR Shareholding
11th Dec 20201:30 pmRNSBlock Listing Return
10th Dec 20205:21 pmRNSBlock Listing Return
8th Dec 202011:04 amRNSAnnual Financial Report
24th Nov 20207:00 amRNSFull Year Results
4th Nov 20202:30 pmRNSHolding(s) in Company
22nd Oct 20204:41 pmRNSHolding(s) in Company
9th Oct 20207:00 amRNSTrading Statement
2nd Oct 202012:45 pmRNSVoting Rights and Capital
24th Sep 20202:26 pmRNSNotification of Transaction of a Director
22nd Sep 20207:00 amRNSNotice of Trading Update
14th Sep 20207:00 amRNSDirector/PDMR Shareholding
1st Sep 20205:27 pmRNSDirector/PDMR Shareholding
26th Aug 20209:29 amRNSBoard Appointment and Board Committee Changes
17th Aug 20205:20 pmRNSDirector/PDMR Shareholding
14th Aug 20205:26 pmRNSDirector/PDMR Shareholding
13th Aug 20204:09 pmRNSHolding(s) in Company
8th Jul 202012:34 pmRNSDirector/PDMR Shareholding
22nd Jun 20202:57 pmRNSHolding(s) in Company
18th Jun 20202:18 pmRNSHolding(s) in Company
15th Jun 20204:57 pmRNSHolding(s) in Company
15th Jun 20207:00 amRNSHolding(s) in Company
1st Jun 202012:32 pmRNSBlock Listing Six Monthly Return
1st Jun 202012:31 pmRNSBlock Listing Six Monthly Return
29th May 20204:27 pmRNSChange of Auditor
22nd May 20202:11 pmRNSDirector Declaration
22nd May 20207:00 amRNSDirector/PDMR Shareholding
19th May 20204:46 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSHalf year/Interim Report
11th May 20208:53 amRNSHolding(s) in Company
7th May 20203:48 pmRNSHolding(s) in Company
6th May 20204:23 pmRNSHolding(s) in Company
29th Apr 202012:51 pmRNSDisclosure of rights attached to equity shares
27th Apr 202012:08 pmRNSSecond Price Monitoring Extn
27th Apr 202012:03 pmRNSPrice Monitoring Extension
24th Apr 20202:12 pmRNSHolding(s) in Company
23rd Apr 20206:23 pmRNSDirector/PDMR Shareholding
17th Apr 20202:06 pmRNSSID and Board Committee Changes
14th Apr 20204:36 pmRNSHolding(s) in Company
9th Apr 20204:43 pmRNSHolding(s) in Company
9th Apr 20204:19 pmRNSTR:1 notification of major holdings
7th Apr 20207:00 amRNSTrading update
26th Mar 202012:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.